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Purpose: The purpose of this work was to assess the feasibility of using surrogate CT scans of
matched patients for organ dose reconstructions for childhood cancer (CC) survivors, treated in the
past with only 2D imaging data available instead of 3D CT data, and in particular using the current
literature standard of matching patients based on similarity in age and gender.
Methods: Thirty-one recently treated CC patients with abdominal CT scans were divided into six
age- and gender-matched groups. From each group, two radiotherapy plans for Wilms’ tumor were
selected as reference plans and applied to the age- and gender-matched patients’ CTs in the respective
group. Two reconstruction strategies were investigated: S1) without field adjustments; S2) with man-
ual field adjustments according to anatomical information, using a visual check in digitally recon-
structed radiographs. To assess the level of agreement between the reconstructed and the reference
dose distributions, we computed (using a collapsed cone algorithm) and compared the absolute devi-
ation in mean and maximum dose normalized by the prescribed dose (i.e., normalized errors |NEmean|
and |NE2cc|) in eight organs at risk (OARs): heart, lungs, liver, spleen, kidneys, and spinal cord. Fur-
thermore, we assessed the quality of a reconstruction case by varying acceptance thresholds for
|NEmean| and |NE2cc|. A reconstruction case was accepted (i.e., considered to pass) if the errors in all
OARs are smaller than the threshold. The pass fraction for a given threshold was then defined as the
percentage of reconstruction cases that were classified as a pass. Furthermore, we consider the impact
of allowing to use a different CT scan for each OAR.
Results: Slightly smaller reconstruction errors were achieved with S2 in multiple OARs than with
S1 (P < 0.05). Among OARs, the best reconstruction was found for the spinal cord (average |NEmean|
and |NE2cc| ≤ 4%). The largest average |NEmean| was found in the spleen (18%). The largest average
|NE2cc| was found in the left lung (26%). Less than 30% of the reconstruction cases (i.e., pass frac-
tion) meet the criteria that |NEmean| < 20% and |NE2cc| < 20% in all OARs when using age and gen-
der matching and a single CT to do reconstructions. Allowing other matchings and combining
reconstructions for OARs from multiple patients, the pass fraction increases substantially to more
than 60%.
Conclusions: To conclude, reconstructions with small deviations can be obtained by using CC
patients’ CT scans, making the general approach promising. However, using age and gender as the
only matching criteria to select a CT scan for the reconstruction is not sufficient to guarantee suffi-
ciently low reconstruction errors. It is therefore suggested to include more features (e.g., height, fea-
tures extracted from 2D radiographs) than only age and gender for dose reconstruction for CC
survivors treated in the pre-3D radiotherapy planning era and to consider ways to combine multiple
reconstructions focused on different OARs. © 2018 American Association of Physicists in Medicine
[https://doi.org/10.1002/mp.12908]
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1. INTRODUCTION
Childhood cancer (CC) survivors who historically received
radiotherapy (RT) are prone to late adverse effects (LAEs).1,2
In contrast with adults, CC patients have a lower tolerance to
radiation and a longer life expectation. The treatment of CC
patients requires specific care and knowledge.3 Understand-
ing how the dose delivered to organs at risk (OARs) relates to
LAEs in CC survivors is key information needed for the
design of RT plans with which a good cure rate of cancer can
be achieved while the LAEs are reduced as much as possible,
offering CC survivors a better quality of life.1,3,4 Retrospec-
tive studies on dose–effect relationships in CC survivors with
long-term follow-up using both clinical information (e.g.,
age, gender, tumor type, metastasis status, LAEs) and treat-
ment information (e.g., treatment modality, intended (pre-
scribed) treatment dose, organ mean dose) have provided
valuable information.5–9 The sensitivity to radiation-induced
second cancers was found to vary with tissue type and dose–
response relationships for various cancer sites were
reported.8,9 However, the relation between radiation dose to
(subvolumes of) OARs and LAEs is still not fully under-
stood.
Associating 3D organ dose to LAEs is hampered by the
fact that 3D dose distributions of the RT plans used on histor-
ical patients are often not available. For patients with long-
term follow-up, CT scans are absent, because when these
patients were treated, 2D imaging data (i.e., simulator films)
were used for RT field localization and dose calculation.10
Moreover, even these historic simulator films are often no
longer available.
To address the absence of 3D images of patients, various
phantom-based methods have been developed for dose recon-
struction.11,12 Anthropomorphic phantoms that are con-
structed of tissue-equivalent material provide possibilities to
directly measure dose to organs. However, the accuracy of
these methods is limited by the rough estimation of the
human anatomy inside these phantoms. Moreover, creating
anthropomorphic phantoms is expensive, time-consuming,
and limited to phantoms of a few sizes.11 Computational
phantoms, using mathematical representations of human
anatomy, originate from stylized phantoms that use simple
3D geometrical shapes (e.g., spheres and cylinders) to repre-
sent human anatomy.13 As tomographic medical imaging
techniques became widely available, voxel-based models
were developed with which better anatomical realism can be
achieved.12–15 In recent studies, so-called boundary represen-
tation phantoms were introduced that combine voxel-based
models with mathematical surface equations, to permit organ
reshaping and repositioning.14,16–18 This allows phantoms to
be deformed to simulate individual anatomy.
Computational phantoms for children have generally been
based on medical images (e.g., CT, MRI) of a patient that has
been considered to be the representative of a group of
patients of a certain age and gender. Features like sitting
height and nonabnormal anatomy are sometimes also taken
into account in the selection of the representative.19 Average
anthropometric and reference organ mass data provided by
public health institutes for specific age and gender groups
were also used to adjust the representative CT-based model
of the respective groups.20,21
Existing computational phantoms do not sufficiently cap-
ture the variations in organ shape, size, and location that are
observed in the population at large.22,23 In a study, phantoms
that represent average male and female anatomies at different
ages (newborn, 1, 5, 15 yr) were adjusted by using image
deformation techniques to form new phantoms based on the
CT scans of individuals of varying age, height, and
weight.24,25 Large anatomical variations, in organ shape and
size, were observed among phantoms representing the same
age and gender.25 Such a phantom library provides some vari-
ation in anatomies of different age, gender, height, and weight
categories, but for the task of providing a good resemblance
of a historical patient’s anatomy, how to match the historical
patient with an existing phantom remains a question. In a
recent study, several patient-to-phantom matching methods
were tested with Monte Carlo-based dose calculation for
CT.26 The results indicated that (a) the water equivalent diam-
eter of the phantom is the superior matching metric, though
the method is less feasible to implement in a retrospective set-
ting; and (b) height-and-weight matching is superior to age-
and-gender matching. However, it is unknown if the same
conclusion goes for RT dosimetry, since the beam energy is
higher, and radiation is focused to a tumor in the patient with
a steep dose gradient in the field boundary.
A more individualized 2D-to-3D dose reconstruction
approach was reported in which 2D imaging of the patients
were used.27 A reference 3D organ model was built and mod-
ified based on patient-specific structural information
extracted from the 2D images. The approach was tested on 15
Hodgkin lymphoma patients with 3D CT planning data avail-
able to analyze the differences between the normal tissue
doses derived from the actual treatment plans and the recon-
structed doses. For the reconstruction approach 2D digitally
reconstructed radiographs (DRRs) generated from the avail-
able 3D CT scans were used to simulate the availability of
only 2D imaging. The median organ mean dose difference
was ≤1 Gy (≤5% of the prescribed dose), which indicates
that this approach is promising. The study was nevertheless
limited to adult patients treated for one type of cancer.
The availability of CT scans of recently treated CC
patients provides possibilities for individualized 3D dose
reconstruction. In particular, it might enable the use of a CT
scan from a patient that closely resembles (i.e., matches) the
historical patient’s anatomy. However, similar to the chal-
lenge for dose reconstruction using computational phantoms,
it is yet unknown how such a CT scan should be selected
based on the data available from historically treated patients
so as to get the best match. In this pilot study, in line with the
previously published phantom-based reconstruction methods,
we therefore tested the suitability of only using age and gen-
der as selection criteria.11,26,28 We focused on Wilms’ tumor
(WT) plans.3 To be able to quantify the quality of the dose
reconstructions (i.e., the agreement with the original dose
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distribution), we used recently treated patients for whom CT
scans and reference plans were available for dose comparison.
Our ultimate goal was to develop an individualized 2D-to-3D
dose reconstruction strategy (3D dose reconstruction for
patients with only 2D imaging data available) to be applied to
data from historically treated patients with long-term follow-
up, to obtain a better understanding of the relation between
treatment and LAEs. As a first step, the aim of this study was
to assess the usability of age- and gender-matched patients’
CT scans for organ dose reconstructions by analyzing the
level of agreement that the approach can achieve between the
reconstructed and the original dose distributions.
2. MATERIALS AND METHODS
2.A. Data preparation
Clinical data of 31 CC patients, who received RT at the
Academic Medical Center/Emma Children’s Hospital in
Amsterdam (n = 28) or at the University Medical Center
Utrecht/Princess Maxima Center for Pediatric Oncology in
Utrecht (n = 3) from 2009 to 2016, with CT scans of the
abdomen available were included in our study. Patients’ ages
at the time of scanning ranged from 2.5 to 5.3 yr. The
patients were divided into six age- and gender-matched
groups such that the age range within each group is ≤1 yr
and the average age of the groups is around 3, 4, or 5 yr.
Detailed information can be found in Table I.
Most patient data included the original RT plan(s), except
for the three patients who received RT in Utrecht, for which
only CT scans were provided for this study. The patients were
diagnosed with different types of CC and WTwas the largest
disease category.
We selected two original WT plans as reference RT plans
from each group. The selected reference plans were typical
flank irradiation treatments with an anterior–posterior–poste-
rior–anterior field setup. According to the clinical SIOP WT
2001 protocol, the treatment field of a typical right-sided RT
plan covers the tumor region including the vertebral column,
the iliac crest, and major parts of the right liver, whereas the
treatment field of a typical left-sided RT plan covers the
major part of the left hemiabdomen with the vertebral col-
umn, the left part of the liver, and the spleen.29 There was
only one exception: the reference plan of one female in the
4.5–5.5 yr age group (i.e., patient 14, reference plan number
6) included partial irradiation of the flank on both sides.
Each reference RT plan was reconstructed by use of the
other patients’ CT scans in the respective age- and gender-
matched group; resulting in a total of 50 dose reconstructions
(two reference plans in group F1 have five reconstructions
each and the other 10 reference plans have four reconstruc-
tions each, see Table I). The 12 reference plans were retrieved
from our archive and together with all CT scans imported to
the Oncentra treatment planning system (TPS) (version 4.3,
Elekta, Stockholm, Sweden). The patient/CT scan on which
the plan was originally calculated is referred to as the refer-
ence patient/CT, and the calculated dose is referred to as the
reference dose. Other patients/CT scans and the calculated
doses within the age- and gender-matched group are referred
to as matched patients/CT scans and reconstructed doses for
that reference plan, respectively. Since for each age- and gen-
der-matched group, there are two reference patients, a refer-
ence patient/CT is at the same time a matched patient/CT for
another reference patient/CT.
To be able to assess errors in organ dose reconstruction,
(partially) in-field OARs were delineated by clinical experts,
including the heart, lungs, liver, spleen, kidney(s), and spinal
cord. For 19 patients, the CT scans did not include full heart
and/or lungs. Furthermore, all the patients diagnosed with WT
(21 out of 31) underwent (partial) nephrectomy. Thus, the (par-
tially) removed kidneys were not delineated for these patients.
2.B. Plan reconstruction strategies
In the Oncentra TPS, reference plans were reconstructed
by applying them to the CT scans in the same age- and gen-
der-matched group. We investigated two strategies to recon-
struct reference plans (see Fig. 1). In both strategies, DRRs
were utilized to a different extent, to simulate the realistic sit-
uation that only 2D simulator films of the historical patients
would be available. The DRRs were derived from the CT
scans using a setting that resulted in an enhancement of bone
structures.
2.B.1. Strategy 1 (S1): identical plan strategy
In this strategy, we duplicated the treatment field without
any adjustments of field size or beam settings. We manually
positioned the reference treatment field on a matched CT, by
using DRRs of the CT scans for visual confirmation. Colli-
mator angles of the beams were also slightly adapted when
necessary to properly align the field when the vertebral col-
umn is bent in different directions compared to the reference.
Out of 50 cases, 26 collimator angles were adapted with a
maximum adaptation of 8°.
2.B.2. Strategy 2 (S2): adjusted-plan strategy
When applying S1, anatomical differences in bone struc-
tures near the field boundaries between reference and
matched CT scans were often visible in the DRRs. Therefore,
in the so-called adjusted-plan strategy (S2), we adjusted the
treatment field, where needed, to correct for the anatomical
differences as visible in the DRR (Fig. 1). The adjusted plans
were checked by an experienced pediatric radiation oncolo-
gist (BVB). In total, 46 of 50 reconstructed plans were
adjusted. In the remaining four cases, no obvious anatomical
differences near the field boundaries were observed.
2.C. Dose reconstruction details
As some of the data dated back to 2006, the original
doses of reference plans were calculated in a previous
TPS using treatment units that are no longer available in
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the current TPS. To enable a consistent comparison, we
calculated all the doses for both reference and matched
CTs in the current TPS using a treatment unit (Elekta
Linac with a multileaf collimator (MLC) beam limiting
device, energy: 6 MV) that is similar to the previous
ones. For reference RT plans that included the use of
blocks that are no longer available in the current TPS,
we used an MLC (leaf width 0.5 cm) as a substitute to
shape the block contour. A collapsed cone algorithm was
used to calculate the dose for all plans.30
The reference doses and the reconstructed doses for S1
were calculated using the original monitor units (MUs) of
the beams as stored in the reference plan. For S2, however,
the field size adjustments influence the collimator and
phantom scatter factors.31 Therefore, after field adjustment,
the MUs were scaled to keep the dose point in the middle
of the field (isocenter) similar to its value before field
adjustment. We observed that the required change in MUs
was less than 1%.
2.D. Error quantification of reconstructions
We compared the reconstructed dose relative to the refer-
ence dose in individual OARs to assess the reconstruction
error. We analyzed two common dose metrics: mean dose
(Dmean) and maximum dose (D2cc, the minimal dose to the
maximally 2 cc exposed volume of the OAR).
To assess the expected error in dose reconstruction, irre-
spective of the prescribed dose, we considered normalized
dose metric errors calculated as the difference in dose
between reconstructed and reference plans normalized by the
prescribed dose (NEmean and NE2cc):
TABLE I. Overview of patient characteristics and grouping (i.e., females were grouped in F1, F2, or F3; males were grouped in M1, M2, or M3). Furthermore, it
is indicated which patients were selected as reference patients. Associated reference plan details (i.e., prescribed dose, number of fractions) are given, and it is
indicated whether the CT scans included full heart/lungs.
Group
Patient
Number
Age
(yr)
Weight
(kg)
Height
(cm)
Wilms’
tumor (Y/N) Tumor site
Used as reference (Y/N) If Y:
prescribed dose (Gy)/fractions
Reference
plan number
Heart/Lungs
complete in CT (Y/N)
F1 1 2.5 14 93 Y Left kidney Y: 14.4/8 1 N/N
2 2.6 13 92 N Left suprarenal gland N N/N
3 2.8 12 NA N Left suprarenal gland N N/N
4 2.9 13 98 Y Right kidney N Y/Y
5 3.1 16 99 Y Right kidney Y: 14.4/8 2 Y/Y
6a 3.2 13 95 Y Left kidney N N/N
F2 7 3.6 15 NA N Left kidney N Y/Y
8 3.6 14 98 Y Right kidney N N/N
9 3.9 18 108 Y Right kidney Y: 14.4/8 3 N/N
10 4.2 20 115 Y Left kidney Y: 14.4/8 4 N/N
11 4.2 16 101 Y Left kidney N Y/Y
F3 12 4.8 15 110 Y Right kidney Y: 14.4/8 5 Y/Y
13 4.8 NA NA N Pelvic region N N/N
14 4.9 22 110 Y Para-aortic metastasis
of WT left kidney
Y: 10.8/6 6 N/N
15 5.3 22 117 Y Left kidney N N/N
16a 5.3 19 118 Y Left kidney N N/N
M1 17a 2.8 18 98 Y Left kidney N N/N
18 3.1 10 92 Y Left kidney Y: 14.4/8 7 Y/Y
19 3.1 13 92 Y Right kidney Y: 25.2/14 8 N/N
20 3.3 15 96 Y Right kidney N Y/N
21 3.3 17 106 N Ductus choledochus N Y/N
M2 22 3.7 14 101 N Right lower abdomen N Y/Y
23 3.8 15 102 Y Right kidney Y: 14.4/8 9 Y/Y
24 3.9 18 104 N Left suprarenal gland N N/N
25 3.9 17 100 N Retroperitoneal N N/N
26 4.2 16 106 Y Left kidney Y: 14.4/8 10 Y/Y
M3 27 4.7 23 119 N Left suprarenal gland N Y/Y
28 4.9 18 105 N 4th ventricle N Y/Y
29 4.9 28 123 Y Right kidney Y: 14.4/8 11 N/N
30 5.1 17 109 N 4th ventricle N Y/Y
31 5.2 18 116 Y Left kidney Y: 14.4/8 12 N/N
aPatient received RT at the University Medical Center Utrecht/Princess Maxima Center for Pediatric Oncology.
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NEx ¼
DxðrecÞ  DxðrefÞ
DpreðrefÞ
 
 100%; x 2 mean, 2ccf g;
(1)
where Dx(rec) and Dx(ref) refer to the reconstructed and ref-
erence dose metrics, respectively, and Dpre(ref) refers to the
prescribed dose of the reference plan. |NEx| quantifies how
large the deviation is compared to the value of dose metric x
in the reference dose relative to the prescribed dose of the ref-
erence plan. The positive or negative sign of NEx indicates
whether it is an overestimation or underestimation of the dose
metric.
Similarly, the relative dose metric errors REmean and RE2cc
in an OAR were calculated as
REx ¼
DxðrecÞ  DxðrefÞ
DxðrefÞ
 
 100%; x 2 mean, 2ccf g:
(2)
Dmean can only be computed based on complete
organs. Because 19 out of 31 CT scans did not contain
complete heart and/or lungs, for heart and lungs only
D2cc was investigated. For matched patients that under-
went (partial) nephrectomy, dose in the (partially)
resected kidney could not be reconstructed. Furthermore,
for right-sided flank irradiation reference plans, the
spleen is an out-of-field organ which received low dose
(<1 Gy). In this pilot study, we excluded the spleen as an
OAR when comparing organ dose of right-sided RT
plans.
2.E. Reconstruction evaluation
We created graphical summaries in the form of boxplots
and bee swarm plots of the dose comparison results in each
OAR, by plotting NEx and REx of all reconstructions using
both strategies. Per OAR, the average and range of the magni-
tude of the normalized and relative errors (i.e., |NEx| and |
REx|) were calculated as well.
In order to assess whether a better reconstruction accuracy
can be achieved with S2 than with S1, we used the paired
Wilcoxon signed-rank statistical hypothesis test. Specifically,
for each dose metric, the H0 hypothesis was that S1 and S2
result in similar average error magnitudes, and the alternative
hypothesis was that S1 results in larger average error magni-
tudes than S2. All the statistical analyses were performed
using R.32 The significance level was set to 0.05.
The previous paragraph focused on the dose reconstruc-
tion error for each individual OAR. To gain insight into the
overall reconstruction quality associated with the use of a
matched CT scan, we considered all OARs in that matched
CT scan jointly. We assessed the quality of a reconstruction
case by varying acceptance thresholds for |NEmean| and |
NE2cc| (denoted by Tmean and T2cc, respectively). A recon-
struction case was accepted (i.e., considered to pass) if the
errors in all OARs are smaller than the threshold. Moreover,
the pass fraction for a given threshold was defined as the per-
centage of the reconstruction cases of all the reference plans
that were classified as a pass:
N represents the total number of reconstructions, and Passi
is a Boolean value that indicates if the ith reconstruction case
is considered a pass under thresholds (Tmean, T2cc). Pass frac-
tions were calculated for S1 and S2 separately.
Furthermore, to investigate what is achievable in terms
of overall dose reconstruction quality if we do not limit
ourselves to the use of only one matched CT scan, we cal-
culated pass fractions by selecting per reference plan for
each OAR the best reconstruction (i.e., the reconstruction
with smallest |NEmean|, or, in case of the heart and lungs,
the smallest |NE2cc|). Combined, these form the best recon-
struction possible for the reference plan. For all the 12 ref-
erence plans, we calculated the pass fraction of these best
reconstructions.
FIG. 1. Left: DRR of reference CT scan and reference RT plan field (green)
of patient 29. Right: DRR of matched CT scan of patient 31 together with the
reference RT plan field (green) as used in strategy 1 (S1) and an RT plan
field adjusted according to the anatomical information (bony structures and
outer body contour) observed in the DRRs (orange) as used in strategy 2
(S2).
Pass fractionðTmean;T2ccÞ¼
PN
i¼1Passi
N
100%;Tmean;T2cc2 5%;10%;...;100%f g;
where
Passi¼
1; if for eachOAR2fheart, lungsgin patient i : jNE2ccðOARÞj\T2cc AND
if for eachOAR2fliver, spleen, kidneys, spinal cordgin patient i : jNEmeanðOARÞj\Tmean and jNE2ccðOAR Þj\T2cc
0; otherwise
8><
>:
Medical Physics, 0 (0), xxxx
5 Wang et al.: Utilizing childhood CTs for 3D dose reconstruction 5
3. RESULTS
The distributions of NEx and REx per OAR for all recon-
structions are visualized in boxplots and bee swarm plots in
Figs. 2 and 3. The different colors of the bee swarm points
represent the corresponding reference plans that were recon-
structed, i.e., each color represents findings associated with a
specific reference plan. It can be observed that the reconstruc-
tion deviations have different distributions in different OARs.
Mostly, the findings associated with the different reference
plans are highly mixed in these distributions which indicate
that the observed variations of dose errors are a general char-
acteristic for the WT plans.
The averages and ranges of |NEx| and |REx| are summa-
rized in Tables II and III, respectively. The average |NEmean|
is smallest for the left kidney, 4% and 3% (n = 13) for S1
and S2, respectively. For the right kidney, located slightly
more caudally than the left kidney to accommodate the liver,
a larger average |NEmean| was found: 9% (n = 16) for both
strategies. For the spinal cord, the average |NEmean| was 6%
and 4% (n = 50) for S1 and S2, respectively. Furthermore,
relatively small ranges of |NEmean| (0%–18% for S1, 0%–13%
for S2) were found for the spinal cord. The largest average
(range) |NEmean| was found for the spleen: 18% (0%–48%)
and 18% (0%–42%) for S1 and S2, respectively. The liver
had |NEmean| ranges comparable to the spleen but smaller
averages (12% and 11% for S1 and S2).
For the lungs, the heart, and the kidneys, large averages
(>10%) and ranges (up to 0%–90%) in |NE2cc| were found,
while for the liver, the spleen, and the spinal cord, smaller
average values for |NE2cc| (<10%) were found.
REx indicates the relative errors compared to the reference
dose. The spinal cord had the smallest average |REmean|: 8%
and 5% for S1 and S2, respectively. For the other four OARs,
compared to the |NEmean| findings, larger averages and ranges
were found for |REmean|: the average varied from 26% to 54%
for S1, and from 20% to 48% for S2.
Large |RE2cc| values were found for the heart and the
lungs, with averages ≥120%. For the kidneys, an average |
RE2cc| around 20% was observed. For the liver, the spleen,
and the spinal cord, the average |RE2cc| values were small
(mostly <5%, except for the spleen with S1), with only sev-
eral outliers (Fig. 3).
Based on both the NEx and REx findings, the most favor-
able results (i.e., best level of agreement, between recon-
structed dose and reference dose and smallest variations
among reconstructions) were obtained for the spinal cord.
The results of the one-sided paired Wilcoxon signed-rank
test indicated that S1 results in larger average |NEmean| than
S2 in the liver (P < 0.004) and the spinal cord (P < 0.001).
For |NE2cc|, significantly larger average values were found for
S1 than S2 in the spleen (P < 0.001) and the spinal cord
(P < 0.04). Furthermore, significantly larger average |REmean|
values for S1 than S2 were found in the liver (P < 0.005) and
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FIG. 2. Boxplots and bee swarm plots of deviations in mean dose and maximum dose normalized by prescribed dose (NEmean and NE2cc) of the reference plan to
OARs between reconstructed plans and reference plans for the two dose reconstruction strategies (S1: applying the identical plan; S2: adjusting the plans accord-
ing to the anatomical information observed in the DRRs). The whiskers extend to the 10th and 90th percentiles, the boxes extend from the 25th to 75th per-
centiles, and the thick horizontal line inside the box indicates the 50th percentile (i.e., the median).
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the spinal cord (P < 0.001). For |RE2cc| significantly larger
average values were found for S1 than S2 in the spleen
(P < 0.001) and the spinal cord (P < 0.04). In summary, the
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FIG. 3. Boxplots and bee swarm plots of relative deviations in mean dose and maximum dose (REmean and RE2cc) to OARs, between reconstructed plans and ref-
erence plans for the two dose reconstruction strategies (S1: applying the identical plan; S2: adjusting the plans according to the anatomical information observed
in the DRRs). The whiskers extend to the 10th and 90th percentiles, the boxes extend from the 25th to 75th percentiles, and the thick horizontal line inside the
box indicates the 50th percentile (i.e., the median).
TABLE II. Average and range of the magnitude of deviations in mean dose
and maximum dose normalized by the prescribed dose of the reference plan
(|NEmean| and |NE2cc|) for two dose reconstruction strategies in OARs.
OARs No. of cases
|NEmean| (%) |NE2cc| (%)
Average (range) Average (range)
S1 S2 S1 S2
Heart 43 12 (0–67) 12 (0–78)
Left lung 39 30 (0–90) 26 (0–90)
Right lung 40 15 (0–89) 13 (0–76)
Liver 50 12 (0–46) 11 (1–42) 4 (0–42) 3 (0–13)
Spleen 25 18 (0–48) 18 (0–42) 9 (0–88) 5 (0–17)
Left kidney 13 4 (0–11) 3 (0–9) 15 (1–43) 14 (1–43)
Right kidney 16 9 (0–28) 9 (0–28) 12 (0–49) 11 (0–49)
Spinal cord 50 6 (0–18) 4 (0–13) 2 (0–5) 2 (0–6)
TABLE III. Average and range of the magnitude of relative deviations in mean
dose and maximum dose (|REmean| and |RE2cc|) for two dose reconstruction
strategies in OARs.
OARs
No. of
cases
|REmean| (%) |RE2cc| (%)
Average (range) Average (range)
S1 S2 S1 S2
Heart 43 120 (0–957) 122 (0–1190)
Left
lung
39 362 (0–1998) 300 (0–2044)
Right
lung
40 144 (0–2033) 125 (0–1738)
Liver 50 30 (1–105) 28 (1–95) 4 (0–45) 2 (0–13)
Spleen 25 44 (0–162) 43 (0–155) 9 (0–88) 4 (0–17)
Left
kidney
13 26 (2–79) 20 (2–52) 21 (1–66) 20 (1–58)
Right
kidney
16 54 (5–148) 48 (0–123) 20 (0–75) 19 (0–75)
Spinal
cord
50 8 (0–25) 5 (0–17) 2 (0–5) 2 (0–6)
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use of S2 yielded better results than the use of S1 for both the
mean dose (in the liver and the spinal cord) and the maxi-
mum dose (the spleen and the spinal cord).
Heat maps illustrating the pass fraction results under dif-
ferent acceptance thresholds are presented in Fig. 4. It can be
observed that for both S1 and S2, pass fractions of <30%
were found when both Tmean and T2cc are smaller than 20%
(i.e., the dose deviation in mean and maximum dose is less
than 20% of the prescribed dose). S2 resulted in slightly
higher pass fractions than S1. For the same threshold values,
Tmean was easier to pass than T2cc. Not being restricted to the
use of only one matched CT scan (i.e., combining the best
reconstruction results obtained for each OAR) resulted in
substantially higher pass fractions (e.g., pass fractions of
>60%, when both Tmean and T2cc are ≥20%).
4. DISCUSSION
In this study, we investigated the usability of CT scans of
matched recently treated CC patients, for 3D dose reconstruc-
tions for CC survivors for whom only 2D imaging data were
available at the time of treatment, and in particular using the
current literature standard of matching patients based on
similarity in age and gender. The use of CT scans from
recently treated patients in combination with a set of refer-
ence treatment plans allowed us to evaluate the deviations
between the doses to the OARs from the reference treatment
plans and the reconstructed doses.
On one hand, our results, with a focus on Wilms’ tumor
patients, indicate that using only age and gender as features to
select CT scans does not guarantee a useful reconstruction of
dose to all OARs (i.e., a reconstruction with small errors in
dose to all OARs). The magnitude of the organ dose metric
deviations using two reconstruction strategies (S1 and S2:
without and with field adaptation, respectively) varied with a
broad range: 0%–48% (S1), 0%–42% (S2) of the prescribed
dose in mean dose (|NEmean|) and 0%–90% (S1 and S2) of
the prescribed dose in maximum dose (|NE2cc|) among recon-
structions and among OARs. For less than 30% of the recon-
structions, an overall reconstruction with deviations smaller
than 20% of the prescribed dose in both mean and maximum
dose in all OARs was achieved.
On the other hand, for individual OARs, more than half of
the reconstructions had a deviation smaller than 20% of the
prescribed dose. When selecting for each OAR, the best pos-
sible reconstruction based on all reconstructions obtained
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FIG. 4. Heat map of pass fractions for reconstructions of all reference plans obtained with the two strategies (S1 and S2) and the best reconstruction possible
(i.e., when we do not limit ourselves to the use of only one matched CT scan) under different acceptance thresholds for normalized errors in mean dose and maxi-
mum dose (|NEmean| and |NE2cc|).
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within the specific age- and gender-matched group (i.e., not
being limited to one matched CT scan), the overall recon-
struction quality therefore improved a lot. These results indi-
cate the potential of using CT scans for 3D dose
reconstruction. However, a more sophisticated selection strat-
egy (i.e., not solely based on age and gender) is needed.
Moreover, next to focusing on how to find one good match-
ing CT scan, the focus could be on finding multiple CT scans
that each provide a good match for a different OAR. Consid-
ering that only four or five age- and gender-matched patients
with CT scans were included in this study, we expect that the
chance of finding a good match will increase if we enlarge
our data set.
The selection of the surrogate CT scan will always depend
on the available data of the historically treated patients.
Sometimes this could mean that no more information other
than the patient’s age and gender is available. It is then impor-
tant to be aware of the potential deviations in dose recon-
structions, as presented in this study.
Two dose reconstruction strategies were investigated:
using the identical plan without field adjustments and, if
needed, manually adjusting the plan according to the anatomy
visible in the DRRs. We considered the adjusted-plan strat-
egy in order to see if we could, to some extent, compensate
for the anatomical differences between the matched and refer-
ence CT scans. Our results indicate that the adjusted-plan
strategy slightly improves the reconstruction quality. A statis-
tically significant improvement was found in the spinal cord,
the liver, and the spleen. For the spinal cord, which is con-
tained within the vertebral column, an overall good recon-
struction accuracy was achieved after field adaptation based
on bony structure (average errors<5%). For organs that are
not fixated due to proximity of bony structure (e.g., spleen),
the field adjustment provided limited improvements, which
indicates that the internal organs’ shape/location is not suffi-
ciently related to the bony structure. Furthermore, organ
motion that is independent of bony structure, can also con-
tribute to organ variations among patients.33
A good dose reconstruction quality was achieved for the
spinal cord, where, compared to the other OARs, a high dose
was delivered. For the kidneys, the average |NEmean| was
smaller than 10%, however, much larger |REmean| values were
found (average |REmean| > 20%). This can be explained by
the low reference dose in the remaining kidneys for WT
plans. Similarly, very large |RE2cc| values were reported for
the lungs and the heart, these OARs are located near the
boundary of the RT field where there is a steep dose gradient.
Thus, the maximum dose values obtained for these OARs
were very much influenced by the organ location relative to
the RT field. In one case for the right lung, the reference D2cc
was 0.63 Gy, and in a reconstruction 13.44 Gy; this led to an
|RE2cc| of 2033%.
The collapsed cone algorithm used to calculate the dose in
this study was reported to underestimate the dose far away
(10–15 cm) from the field boundary.34 However, the OARs
included in this study are either in field or in the vicinity of
the field boundary (<5 cm), where the agreement between
the calculations and measurements obtained in the dose is
reported to be between 1% and 2% of the prescribed dose.35
For studies interested in OARs that are further away from the
field boundary, a more advanced dose calculation method
that can accurately estimate the out-of-field (>10 cm) dose is
needed.
A key question is what constitutes a proper notion of accu-
racy for dose reconstruction and what level of accuracy is
needed for clinical research purposes. There is no clear
answer currently. However, in the study about an individual-
ized 2D-to-3D dose reconstruction approach we mentioned
in the introduction, it was claimed that a median mean dose
difference of 1 Gy (5% of the prescribed dose) between the
reconstructed and actual RT plan would not be the weak link
in the chain of estimating dose–risk relationships given the
dose precision used in existing modeling studies.27 In our
study, the prescribed dose for 10 out of 12 reference plans
was 14.4 Gy, which means that 20% of the prescribed dose is
around 3 Gy. Based on the pass fraction findings associated
with 20% thresholds, we believe that using solely age- and
gender-matched anatomies for 2D-to-3D dose reconstruction
could make an undesired difference in the dose–effect estima-
tion model. Also, it is hard to compare our current results
with other published methods because the reported dose
reconstruction errors used different dose metrics and focused
on different tumor types and patients’ age groups. The previ-
ously mentioned 2D-to-3D dose reconstruction approach uti-
lized more information (i.e., 2D radiographs) than just age
and gender for anatomy matching.27 It is therefore under-
standable that it yielded more accurate dose reconstruction
results.
We quantified the reconstruction quality by assessing the
pass fractions associated with different thresholds on dose
metric deviations normalized by prescribed dose. In the pass
fraction calculation, we combined the thresholds of the mean
dose and the maximum dose; however, it is yet unclear if the
error in estimating the mean dose and the maximum dose will
lead to similar errors in dose–effect estimation models.
There are limitations to this study. First, the number of
included patients for this pilot study is small. With only five
or six patients in each age- and gender-matched group and
six groups in total, we cannot achieve highly confident esti-
mates of the variation in dose reconstruction deviations.
However, even with our small numbers, negative conclusions
on using solely age and gender as matching features can
clearly be drawn. Secondly, it is hard to delineate gender-spe-
cific organs such as the glandular breast tissue and the ovaries
that are not clearly visible in the CT scans, thus in this pilot
study, these OARs were not included. Thirdly, the focus on
Wilms’ tumor reference plans only provides insights on dose
reconstruction quality for this specific type of RT plan.
In this study, we directly compared dose metrics. Detailed
spatial information of the 3D distribution is not taken into
account. It would be more informative if we could perform a
voxel-to-voxel 3D dose comparison. However, this requires a
reliable and accurate way to compensate for differences in
shape and location of organs among patients to make direct
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3D dose comparison possible. One approach is deformable
image registration, but this would introduce new uncertainties
to the dose, as current solutions do not guarantee anatomical
correctness of deformations. Without anatomical landmarks
or fiducial implanted markers available in the imaging data, it
is difficult to report the accuracy of registration of organs.36
Nevertheless, 3D/2D deformable image registration
between the matched CT scan and the available 2D image(s)
of the reference patient can potentially (partially) compensate
for residual mismatches.37 However, since such a registration
will mostly be guided by the outer body contour and bony
structures visible in the 2D images, this compensation will
most likely mainly be in size and/or shape of the matched
patient and not in organ locations.
5. CONCLUSIONS
Using age and gender as matching features (i.e., the cur-
rent literature standard) for 2D-to-3D dose reconstruction for
CC survivors, does not result in a sufficiently robust recon-
struction. Adapting the RT field based on the bony structure
visible in DRRs slightly reduces reconstruction deviations,
but this is not substantial for all OARs. However, there are
combinations of patients for which a dose reconstruction with
sufficiently small errors is achievable, especially when OARs
may be selected from different patients. As such, a dose
reconstruction method based on similar patients’ CT scans
can be said to be promising to provide accurate organ dose
reconstructions for CC survivors.
In future studies, we therefore aim to develop a method
that will be able to automatically select the most similar CT
scan for dose reconstruction, based on a more extensive set of
patients’ characteristics and features (extracted from e.g., the
2D simulator films). A larger patient data library is currently
being built up. As one of the next steps, we will investigate
the anatomical variation among CC patients and relate it to
the dose reconstruction quality. Ultimately, our goal was to
develop a method that provides sufficiently accurate 2D-to-
3D dose reconstructions so that these can be used in the
investigation of dose–effect relationships in CC survivors
with long-term follow-up.
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